This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michelet, C.
Right arrow Articles by Cartier, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michelet, C.
Right arrow Articles by Cartier, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 01 1997, 60-65, Vol 41, No. 1
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes

C Michelet, JL Avril, C Arvieux, C Jacquelinet, N Vu and F Cartier
Clinique des Maladies Infectieuses, Centre Hospitalier, Regional et Universitaire, Rennes, France.

We studied the activities of the new fluoroquinolones clinafloxacin, levofloxacin, ofloxacin, and sparfloxacin alone or in combination on the intracellular growth of Listeria monocytogenes. Against intracellular growth of the four strains tested, a similar reduction of the bacterial count was obtained with clinafloxacin at the dose of 10 x MIC (delta log10 CFU/ml = -2.19 +/- 0.24), with levofloxacin at 8 x MIC (delta log10 CFU/ml = -2.28 +/- 0.25), and with sparfloxacin at 4 x MIC (delta log10 CFU/ml = -2.16 +/- 0.21) after 24 h of incubation. The combination of the quinolones with trimethoprim-sulfamethoxazole or amoxicillin did not show a substantial increase in activity compared to the fluoroquinolone alone. Antagonism with rifampin was strongly suggested. No modification of the MIC was observed after 20 successive infections of HeLa cells and contact with subinhibitory concentrations of clinafloxacin, levofloxacin, and sparfloxacin for 24 h. We conclude that clinafloxacin, levofloxacin, or sparfloxacin could represent a therapeutic alternative to amoxicillin for the treatment of Listeria infections in adults, especially clinafloxacin, whose MIC is low (0.06 to 0.12 micrograms/ml), and whose best activity against intracellular L. monocytogenes was obtained at a concentration of 1.2 micrograms/ml, which is similar to clinically achievable levels. The results must be confirmed in an experimental model.


This article has been cited by other articles:

  • Grayo, S., Lott-Desroches, M.-C., Dussurget, O., Respaud, R., Fontanet, A., Join-Lambert, O., Singlas, E., Le Monnier, A. (2008). Rapid Eradication of Listeria monocytogenes by Moxifloxacin in a Murine Model of Central Nervous System Listeriosis. Antimicrob. Agents Chemother. 52: 3210-3215 [Abstract] [Full Text]  
  • Grayo, S., Join-Lambert, O., Desroches, M. C., Le Monnier, A. (2008). Comparison of the In Vitro Efficacies of Moxifloxacin and Amoxicillin against Listeria monocytogenes. Antimicrob. Agents Chemother. 52: 1697-1702 [Abstract] [Full Text]  
  • Seral, C., Barcia-Macay, M., Mingeot-Leclercq, M. P., Tulkens, P. M., Van Bambeke, F. (2005). Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. J Antimicrob Chemother 55: 511-517 [Abstract] [Full Text]  
  • Michot, J.-M., Van Bambeke, F., Mingeot-Leclercq, M.-P., Tulkens, P. M. (2004). Active Efflux of Ciprofloxacin from J774 Macrophages through an MRP-Like Transporter. Antimicrob. Agents Chemother. 48: 2673-2682 [Abstract] [Full Text]  
  • Safdar, A., Armstrong, D. (2003). Antimicrobial Activities against 84 Listeria monocytogenes Isolates from Patients with Systemic Listeriosis at a Comprehensive Cancer Center (1955-1997). J. Clin. Microbiol. 41: 483-485 [Abstract] [Full Text]  
  • Carryn, S., Van Bambeke, F., Mingeot-Leclercq, M.-P., Tulkens, P. M. (2002). Comparative Intracellular (THP-1 Macrophage) and Extracellular Activities of {beta}-Lactams, Azithromycin, Gentamicin, and Fluoroquinolones against Listeria monocytogenes at Clinically Relevant Concentrations. Antimicrob. Agents Chemother. 46: 2095-2103 [Abstract] [Full Text]  
  • Blanot, S., Boumaila, C., Berche, P. (1999). Intracerebral activity of antibiotics against Listeria monocytogenes during experimental rhombencephalitis. J Antimicrob Chemother 44: 565-568 [Abstract] [Full Text]  
  • Ogtrop, M. L. v. (1999). The antibacterial efficacy of trovafloxacin against an experimental infection with Listeria monocytogenes in hydrocortisone-treated mice. J Antimicrob Chemother 44: 229-234 [Abstract] [Full Text]  
  • Michelet, C., Leib, S. L., Bentue-Ferrer, D., Täuber, M. G. (1999). Comparative Efficacies of Antibiotics in a Rat Model of Meningoencephalitis Due to Listeria monocytogenes. Antimicrob. Agents Chemother. 43: 1651-1656 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»